Intravenous immunoglobulin products contain specific antibodies to recombinant human tau protein

International Immunopharmacology

Volumn 16, Issue 4, 2013, Pages 424-428

  Smith, Lynnae M ^a   Coffey, Mary P ^a   Klaver, Andrea C ^a   Loeffler, David A ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Alzheimer's disease; Antibodies; ELISA; Intravenous immunoglobulin; IVIG; Tau

Indexed keywords

HUMAN IMMUNOGLOBULIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; PROTEIN ANTIBODY; RECOMBINANT PROTEIN; TAU ANTIBODY; TAU PROTEIN; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIGEN BINDING; ARTICLE; COVALENT BOND; ENZYME LINKED IMMUNOSORBENT ASSAY; PRIORITY JOURNAL; PROTEIN BINDING;

ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; PROTEIN BINDING; RECOMBINANT PROTEINS; TAU PROTEINS;

EID: 84878408877     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2013.04.034     Document Type: Article

References (40)

1. M.P. Mazanetz, and P.M. Fischer Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases Nat Rev Drug Discov 6 2007 464 479
2. A. Gómez-Ramos, M.A. Smith, G. Perry, and J. Avila Tau phosphorylation and assembly Acta Neurobiol Exp (Wars) 64 2004 33 39
3. D.P. Hanger, H.L. Byers, S. Wray, K.Y. Leung, M.J. Saxton, and A. Seereeram Novel phosphorylation sites in tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis J Biol Chem 282 2007 23645 23654
4. T. Jaworski, S. Kügler, and F. Van Leuven Modeling of tau-mediated synaptic and neuronal degeneration in Alzheimer's disease Int J Alzheimers Dis 2010 2010
5. S.M. Ward, D.S. Himmelstein, J.K. Lancia, and L.I. Binder Tau oligomers and tau toxicity in neurodegenerative disease Biochem Soc Trans 40 2012 667 671
6. O. Wirths, G. Multhaup, and T.A. Bayer A modified beta-amyloid hypothesis: intraneuronal accumulation of the beta-amyloid peptide - the first step of a fatal cascade J Neurochem 91 2004 513 520
7. C.L. Masters, and D.J. Selkoe Biochemistry of amyloid β-protein and amyloid deposits in Alzheimer disease Cold Spring Harb Perspect Med 2 2012 a006262
8. N.S. Scheinfeld Intravenous immunoglobulin. Medscape reference: drugs, diseases & procedures updated June 26, 2012 http://emedicine.medscape.com/ article/210367-overview 2012
9. M.D. Kazatchkine, and S.V. Kaveri Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin N Engl J Med 345 2001 747 755
10. R. Dodel, H. Hampel, C. Depboylu, S. Lin, F. Gao, and S. Schock Human antibodies against amyloid beta peptide: a potential treatment for Alzheimer's disease Ann Neurol 52 2002 253 256
11. R.C. Dodel, Y. Du, C. Depboylu, H. Hampel, L. Frölich, and A. Haag Intravenous immunoglobulins containing antibodies against beta-amyloid for the treatment of Alzheimer's disease J Neurol Neurosurg Psychiatry 75 2004 1472 1474
12. N.R. Relkin, P. Szabo, B. Adamiak, T. Burgut, C. Monthe, and R.W. Lent 18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease Neurobiol Aging 30 2009 1728 1736
13. ClinicalTrials.gov A phase 3 study evaluating safety and effectiveness of immune globulin intravenous (IGIV 10%) for the treatment of mild-to-moderate Alzheimer's disease ClinicalTrials.gov Identifier: NCT00818662 http://clinicaltrials.gov/ct2/show/NCT00818662 [accessed 11-15-12]
14. ClinicalTrials.gov A study to evaluate albumin and immunoglobulin in Alzheimer's disease (AMBAR) ClinicalTrials.gov Identifier: NCT01561053 http://clinicaltrials.gov/show/NCT01561053 [accessed 11-15-12]
15. H. Rosenmann, Z. Meiner, V. Geylis, O. Abramsky, and M. Steinitz Detection of circulating antibodies against tau protein in its unphosphorylated and in its neurofibrillary tangles-related phosphorylated state in Alzheimer's disease and healthy subjects Neurosci Lett 410 2006 90 93
16. L. Fialová, A. Bartos, J. Svarcová, and I. Malbohan Increased intrathecal high-avidity anti-tau antibodies in patients with multiple sclerosis PLoS One 6 2011 e27476
17. A.C. Klaver, L.M. Patrias, M.P. Coffey, J.M. Finke, and D.A. Loeffler Measurement of anti-Abeta1-42 antibodies in intravenous immunoglobulin with indirect ELISA: the problem of nonspecific binding J Neurosci Methods 187 2010 263 269
18. P. Szabo, D.M. Mujalli, M.L. Rotondi, R. Sharma, A. Weber, and H.P. Schwarz Measurement of anti-beta amyloid antibodies in human blood J Neuroimmunol 227 2010 167 174
19. A.A. Asuni, A. Boutajangout, D. Quartermain, and E.M. Sigurdsson Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements J Neurosci 27 2007 9115 9129
20. M. Boimel, N. Grigoriadis, A. Lourbopoulos, E. Haber, O. Abramsky, and H. Rosenmann Efficacy and safety of immunization with phosphorylated tau against neurofibrillary tangles in mice Exp Neurol 224 2010 472 485
21. A. Boutajangout, D. Quartermain, and E.M. Sigurdsson Immunotherapy targeting pathological tau prevents cognitive decline in a new tangle mouse model J Neurosci 30 2010 16559 16566
22. X. Chai, S. Wu, T.K. Murray, R. Kinley, C.V. Cella, and H. Sims Passive immunization with anti-Tau antibodies in two transgenic models: reduction of Tau pathology and delay of disease progression J Biol Chem 286 2011 34457 34467
23. A. Boutajangout, J. Ingadottir, P. Davies, and E.M. Sigurdsson Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain J Neurochem 118 2011 658 667
24. H. Rosenmann, N. Grigoriadis, D. Karussis, M. Boimel, O. Touloumi, and H. Ovadia Tauopathy-like abnormalities and neurologic deficits in mice immunized with neuronal tau protein Arch Neurol 63 2006 1459 1467
25. M.J. Cheng, and C. Christmas Special considerations with the use of intravenous immunoglobulin in older persons Drugs Aging 28 2011 729 736
26. T. Taniguchi, M. Sumida, S. Hiraoka, K. Tomoo, T. Kakehi, and K. Minoura Effects of different anti-tau antibodies on tau fibrillogenesis: RTA-1 and RTA-2 counteract tau aggregation FEBS Lett 579 2005 1399 1404
27. G. Istrin, E. Bosis, and B. Solomon Intravenous immunoglobulin enhances the clearance of fibrillar amyloid-beta peptide J Neurosci Res 84 2006 434 443
28. J. Magga, L. Puli, R. Pihlaja, K. Kanninen, S. Neulamaa, and T. Malm Human intravenous immunoglobulin provides protection against Aβ toxicity by multiple mechanisms in a mouse model of Alzheimer's disease J Neuroinflammation 7 2010 90
29. A.C. Klaver, J.M. Finke, J. Digambaranath, M. Balasubramaniam, and D.A. Loeffler Antibody concentrations to Abeta1-42 monomer and soluble oligomers in untreated and antibody-antigen-dissociated intravenous immunoglobulin preparations Int Immunopharmacol 10 2010 115 119
30. A. Widiapradja, V. Vegh, K.Z. Lok, S. Manzanero, J. Thundyil, and M. Gelderblom Intravenous immunoglobulin protects neurons against amyloid beta-peptide toxicity and ischemic stroke by attenuating multiple cell death pathways J Neurochem Apr 12 2012 10.1111/j.1471-4159.2012.07754.x [Epub ahead of print]
31. D.R. Lachno, M.J. Romeo, E.R. Siemers, H. Vanderstichele, E. Coart, and R.J. Konrad Validation of ELISA methods for quantification of total tau and phosporylated-tau181 in human cerebrospinal fluid with measurement in specimens from two Alzheimer's disease studies J Alzheimers Dis 26 2011 531 541
32. M.A. Wozniak, and R.F. Itzhaki Intravenous immunoglobulin reduces beta amyloid and abnormal tau formation caused by Herpes simplex virus type 1 J Neuroimmunol 257 2013 7 12
33. V. Vingtdeux, N. Sergeant, and L. Buée Potential contribution of exosomes to the prion-like propagation of lesions in Alzheimer's disease Front Physiol 3 2012 229
34. R.W. Shin, T. Iwaki, T. Kitamoto, and J. Tateishi Hydrated autoclave pretreatment enhances tau immunoreactivity in formalin-fixed normal and Alzheimer's disease brain tissues Lab Invest 64 1991 693 702
35. H. Zetterberg, D. Wilson, U. Andreasson, L. Minthon, K. Blennow, and J. Randall Plasma tau levels in Alzheimer's disease Alzheimers Res Ther 5 2013 9
36. K. Balakrishnan, L.C. Andrei-Selmer, T. Selmer, M. Bacher, and R. Dodel Comparison of intravenous immunoglobulins for naturally occurring autoantibodies against amyloid-beta J Alzheimers Dis 20 2010 135 143
37. B.M. Reipert, M.T. Stellamor, M. Poell, J. Ilas, M. Sasgary, and S. Reipert Variation of anti-Fas antibodies in different lots of intravenous immunoglobulin Vox Sang 94 2008 334 341
38. M.G. Mikolajczyk, N.F. Concepcion, T. Wang, D. Frazier, B. Golding, and C.E. Frasch Characterization of antibodies to capsular polysaccharide antigens of Haemophilus influenzae type b and Streptococcus pneumoniae in human immune globulin intravenous preparations Clin Diagn Lab Immunol 11 2004 1158 1164
39. L.M. Patrias, A.C. Klaver, M.P. Coffey, and D.A. Loeffler Specific antibodies to soluble alpha-synuclein conformations in intravenous immunoglobulin preparations Clin Exp Immunol 161 2010 527 535
40. D. Lejtenyi, and B. Mazer Consistency of protective antibody levels across lots of intravenous immunoglobulin preparations J Allergy Clin Immunol 121 2008 254 255